SKT, SK Biopharm Use AI to Cut Drug Discovery Time by 60%
SK Telecom and SK Biopharmaceuticals used AI to discover two early lead compounds for intractable cancer therapies, cutting drug research time by more than 60%, from 1-2 years to five months.
Read the full articleYou might also wanna read
AI accelerates search for cancer therapeutics in Korea
Artificial intelligence (AI) has helped SK Telecom and SK Biopharmaceuticals identify promising early compounds for a targeted cancer therap
How AI Will Transform Biopharma: The Sequence of Change Matters
How AI will transform biopharma—and why the sequence of change matters
a16z.news·25d ago
AI Advances in Drug Discovery: From Data Integration to Dual-Action Cancer Drug Design
Featured content
drugtargetreview.com·5mo agoFrom linear gates to learning loops: Rewiring biopharma R&D with AI
An AI-powered R&D model built on connected decision loops—replacing the current sequential, fragmented workflow—can reduce uncertainty, comp
Pharma’s AI Boom Has Bet on the Wrong Bottleneck
Investors have poured billions into using artificial intelligence to discover new drugs, and 2026 is the first real test of whether AI-desig
CMU Startup Pierogi Therapeutics Uses AI to Accelerate Radiopharmaceutical Cancer Drug Discovery
A Carnegie Mellon University startup is using advanced chemistry and artificial intelligence to help speed up the search for new cancer drug
cmu.edu·1mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.